Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Coinbase Global, Inc. (COIN) vs GSK plc (GSK) Price & Performance

Coinbase Global, Inc.Trade
GSK plcTrade

Price performance (Past 24H)

Key statistics

Coinbase Global, Inc. vs GSK plc — how do they compare? Coinbase Global, Inc. trades at $163.53 (market cap $42.55B), while GSK plc trades at $51.21 (market cap $101.55B). The key difference: GSK plc is far larger — about 2.4× Coinbase Global, Inc.'s market cap, and GSK plc pays a 3.5% dividend while Coinbase Global, Inc. pays none. Which is the better fit depends on your goals.

COINGSK
Market Cap
$42.55B$101.55B
Sector
TechnologyHealth
52-Week High
$419.78$61.18
52-Week Low
$141.09$36.20
Enterprise Value
$39.83B$122.16B
Dividend Yield
3.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Coinbase Global, Inc.

No Aura AI signal available yet.

GSK plc

GSK trades at $52.29, down 0.93% with neutral technical signals. The company shows strong fundamentals with Q1 2026 EPS beating expectations at $1.24 versus $1.16 forecast. Recent FDA approvals for Utebzi and positive Jemperli trial results highlight pipeline strength. Valuation metrics appear reasonable with P/E of 13.94 and ROE of 36.42%.

GSK presents a balanced investment case with solid profitability and promising drug pipeline offset by mixed analyst sentiment and competitive pressures. The stock offers income potential with 3.46% dividend yield but faces execution risks in drug development and market competition.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Coinbase Global, Inc.

Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.

Read more on COIN

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK